Home/Filings/4/0001213900-20-015098
4//SEC Filing

Beck Philip D 4

Accession 0001213900-20-015098

CIK 0001534154other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:00 PM ET

Size

12.3 KB

Accession

0001213900-20-015098

Insider Transaction Report

Form 4
Period: 2020-06-11
Beck Philip D
DirectorCEO/President/Chairman
Transactions
  • Other

    Stock Options

    2020-06-11$0.05/sh3,000,000$150,00017,000,000 total(indirect: See footnote)
    Exercise: $0.05From: 2016-08-10Exp: 2026-08-10Common Stock, $0.0001 par value per share (3,000,000 underlying)
Holdings
  • 15% Convertible Note

    Exercise: $0.20From: 2020-02-14Exp: 2022-02-28Common Stock, $0.0001 par value per share (375,000 underlying)
    375,000
  • Stock Options

    Exercise: $0.10From: 2017-01-31Exp: 2027-01-31Common Stock, $0.0001 par value per share (15,000,000 underlying)
    15,000,000
  • Common Stock, $.0001 par value

    16,000,000
  • Common Stock, $.0001 par value

    (indirect: See Footnote)
    1,125,000
  • 8% Convertible Note

    Exercise: $0.08From: 2019-12-13Exp: 2022-02-28Common Stock, $0.0001 par value per share (312,500 underlying)
    312,500
Footnotes (4)
  • [F1]Shares held by an individual retirement account.
  • [F2]Includes 15,000,000 shares of common stock acquired by Mr. Beck in accordance with a restricted stock purchase agreement dated September 29, 2017. Pursuant to the letter agreement entered between Ipsidy Inc. (the "Company") and Mr. Beck dated May 22, 2020 the vesting criteria for the restricted shares of common stock was amended as follows: (1) satisfaction of the Performance Goals set forth under the Restricted Stock Agreement, (2) on the date that the Company either fails to re-nominate or re-elect Mr. Beck as a Director, or as Chairman of the Company's Board of Directors, or (3) on the two year anniversary if Mr. beck is continuing to provide services to the Company in any capacity.
  • [F3]On June 11, 2020, Parity Labs LLC, a private consulting firm which is principally owned by Mr. Beck, assigned a portion of its stock option to Graham Beck. Following the transaction, Parity Labs LLC continues to hold a stock option to acquire 17,000,000 shares of common stock at $0.05 per share.
  • [F4]In connection with the Company's private offering, Mr. Beck acquired a 15% Convertible Note. The 15% Convertible Note is convertible into an amount equal to 150% of the principal amount due under the 15% Convertible Note divided by the conversion price of $0.20 per share.

Documents

1 file

Issuer

Ipsidy Inc.

CIK 0001534154

Entity typeother

Related Parties

1
  • filerCIK 0001562101

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:00 PM ET
Size
12.3 KB